Treatment Registry

Company

NovoCare Pharmacy

NovoCare Pharmacy publishes brand semaglutide, from $50 to $149 a month.

  • 2 programs
  • 1 molecule
  • 2 readings

Read from novocare.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to NovoCare Pharmacy

Visit NovoCare Pharmacy

We earn nothing from this link. NovoCare Pharmacy has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

What it costs

Brand semaglutideInjection, pen$50

first month, including the required fees on record · Medicare price, Medicare GLP-1 Bridge program

Brand semaglutideOral tablet$149

first month, including the required fees on record · Cash/self-pay price via NovoCare Pharmacy, by dose

Terms

Not yet checked: pharmacy, membership, consultation fee and states.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderFormPer month
at its shortest term
Link
TR-0198NovoCare PharmacyInjection, pen$50
Medicare price, Medicare GLP-1 Bridge program
Record
TR-0199NovoCare PharmacyOral tablet$149
Cash/self-pay price via NovoCare Pharmacy, by dose
Record

Notes

Recorded against this company rather than one program.

September 2, 2026

  1. 1. This is Novo Nordisk's own manufacturer site (novocare.com), not an independent telehealth provider — 'NovoCare Pharmacy' is Novo Nordisk's own direct-fulfillment pharmacy program for its brand Wegovy, and this page assumes the patient already has a prescription from their own doctor ('take it to your pharmacy with your prescription'); there is no telehealth consult or prescribing service offered on this page, so prescriber is not-found rather than guessed. Three separate published prices exist for the same drug depending on payer: a commercial-insurance copay as low as $25/month (capped at $100/month in savings), a Medicare price of $50/month via the 'Medicare GLP-1 Bridge program,' and self-pay/cash prices through NovoCare Pharmacy that vary by dose and form ($199/mo rising to $349-$399/mo for the injection pen after an introductory period; $149-$299/mo by dose for the tablet). All are recorded as separate entries per the brief's insurance-vs-cash rule. No cancellation/return policy or served-state list appears on this page; full terms are referenced at external domains (WegovyTerms.com, NovoCarePharmacyTerms.com) that were not part of this fetch.

Before you act

Cite this

Treatment Registry. (2026). NovoCare Pharmacy: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/novocare-pharmacy